Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
08/2005
08/24/2005CN1658834A Method of treating mucus hypersecretion
08/24/2005CN1658759A Insecticidal amides with nitrogen-containing benzo-fused bicyclic ring systems
08/24/2005CN1657524A Substituted azole compounds and their preparation and application
08/24/2005CN1657523A Cyclic compounds
08/24/2005CN1216056C Sulfamato hydroxamic acid metalloprotease inhibitor
08/24/2005CN1216054C 1,4-dihydro pyridine-3,5-carboxylic-acid derivatives and preparation method thereof
08/23/2005US6933390 Process for the arylation of aza-heterocycles with activated aromatics in presence of caesium carbonate
08/23/2005US6933389 Process for preparation of crystalline form-1 of pantoprazole sodium sesquihydrate
08/23/2005US6933316 Indole compounds
08/23/2005US6933311 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
08/23/2005US6933306 Anticancer agents; antiinflammatory agents; autoimmune disease
08/23/2005US6933296 A 2H-pyridazine-1-one derivatives as bronchodilator agents for the treatment of asthma, chronic obstructive pulmonary disease, respiratory system disorders
08/23/2005US6932960 Complexes with radionuclides; for use as contrast agent in magnetic resonance imaging (MRI); as parasiticide, viricide, or as chelation therapy of iron overload such as thalassemia; optimal combination of lipophilicity and hydrophilicity
08/23/2005CA2370888C Renin inhibitors
08/23/2005CA2310585C Novel administration form comprising an acid-labile active compound
08/23/2005CA2138288C Substituted azabicycloheptane derivatives, their preparation and use
08/23/2005CA2109161C Substituted 1-h-3-aryl-pyrrolidine-2,4-dione derivatives
08/23/2005CA2064373C Piperidine derivatives
08/18/2005WO2005075574A1 Neutral and cationic naphthalene derivatives and dyes containing said compounds for dyeing keratin fibers
08/18/2005WO2005075459A1 Synthesis of cyanoimino-benzoimidazoles
08/18/2005WO2005075458A1 Pyrimidine derivatives as orexin receptors antagonists
08/18/2005WO2005075457A1 Phthalazinone-derivatives as pde4 inhibitors
08/18/2005WO2005075456A1 2-(piperidin-4-yl) -4, 5-dihydro-2h-pyridazin-3-one derivatives as pde4 inhibitors
08/18/2005WO2005075455A2 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds
08/18/2005WO2005075454A2 SALT FORMS OF 4-(4-METHYLPIPERAZIN-1-YLMETHYL)-n-[4-METHYL-3-(4-PYRIDIN-3-YL)PYRIMIDIN-2-YLAMINO)PHENYL]-BENZAMIDE
08/18/2005WO2005075439A1 Quinazoline derivatives
08/18/2005WO2005075437A1 Pyridazinone derivatives and their use as pde4 inhibitors
08/18/2005WO2005075429A1 Novel quinoline-carbaxamides as jack3 kinase modulators
08/18/2005WO2005075426A1 Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof
08/18/2005WO2005075425A2 Substituted bisarylurea derivatives as kinase inhibitors
08/18/2005WO2005075424A1 New pyridin-2-one compounds useful as inhibitors of thrombin
08/18/2005WO2005074933A1 Small molecule inhibitors of her2 expression
08/18/2005WO2005074929A2 Calcium, potassium, zinc, lithium and aluminium salts of pantoprazole and (s)-pantoprazole
08/18/2005WO2005074919A1 Diurea derivatives
08/18/2005WO2005074872A1 Lightening direct dyestuffs for keratin fibers and dyes containing said compounds
08/18/2005WO2005074642A2 Chemical compounds
08/18/2005WO2005030794A3 Hemiasterlin derivatives and uses thereof
08/18/2005WO2005013909A3 Novel cathepsin k inhibitors
08/18/2005US20050182256 1-{1-[4-(6-hydroxy-5-isobutyl-3-phenylpyrazin-2-yl)benzyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one; antiproliferative
08/18/2005US20050182120 Fungicides, microbiocides
08/18/2005US20050182116 Such as 5-amino-3-[[4-(aminosulfonyl)phenyl]amino]-N-(2,6-difluorophenyl)-1H-1,2,4-triazole-1-carbothioamide, used as cyclin dependent and tyrosine kinase inhibitors, for prophylaxis of tumors
08/18/2005US20050182110 tetracylic bridged ring compounds such as 9-nitro-11-amino-11-((imidazol-2-yl)aminocarbonyl)-9,10-dihydro-9,10-ethanoanthracene; treating obesity, diabetes and inflammatory or immune associated diseases; nuclear factor kappa beta (NF-KB)
08/18/2005US20050182103 Substituted 2,3-diphenyl pyridines
08/18/2005US20050182101 Prodrugs of proton pump inhibitors
08/18/2005US20050182099 Alkylammonium salts of omepazole and esomeprazole
08/18/2005US20050182095 Piperdine derivatives useful as CCR3 antagonists
08/18/2005US20050182093 Novel compounds
08/18/2005US20050182092 Crystalline form of a biphenyl compound
08/18/2005US20050182082 Modulators of the glucocorticoid receptor, AP-1, and/or NF-kB activity and use thereof
08/18/2005US20050182079 Tetrahydroisoquinolinyl derivatives of quinazoline and isoquinoline
08/18/2005US20050182073 Controlling microorganisms; e.g. agricultural fungicides; preservatives for e.g. lubricants, paints; chemical intermediates and synthesis thereof
08/18/2005US20050182072 Paget's disease; muscular disorders; cardiovascular disorders; antiinflamamtory agents; antidiabetic agents; autoimmune disease; leukemia
08/18/2005US20050182068 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
08/18/2005US20050182067 Vanilloid receptor ligands and their use in treatments
08/18/2005US20050182061 Phthalimide compounds useful as protein kinase inhibitors
08/18/2005US20050182050 Therapeutic heterocyclic compounds
08/18/2005US20050182048 Paraciticides for use on or in animals, against insects, arachnids and nematodes; 1-(haloalkyl-substituted aryl)-3-cyano-4-alkylthio-5-(alkylthioalkylamino)pyrazoles or S-oxides thereof
08/18/2005US20050182047 Treatment of demyelinating disorders
08/18/2005US20050182045 Fused ring 4-oxopyrimidine derivative
08/18/2005US20050182043 4-amino-6-cycloalkyloxy-7-substituted quinazolines; inhibition of signal transduction mediated by tyrosine kinases; antitumor agents, respiratory system and gastrointestinal disorders
08/18/2005US20050181393 Novel chelating agents and highly luminescent and stable chelates and their use
08/18/2005DE102004002885A1 New pyrrole alkaloid daminin and its derivatives, are intracellular calcium ion concentration reducing neuroprotective agents useful for treating neurodegenerative diseases, e.g. Alzheimer's disease
08/18/2005CA2720312A1 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds
08/18/2005CA2555219A1 Synthesis of cyanoimino-benzoimidazoles
08/18/2005CA2554878A1 Bisarylurea derivatives
08/18/2005CA2554260A1 Calcium, potassium, zinc, lithium and aluminium salts of pantoprazole and (s)-pantoprazole
08/18/2005CA2553887A1 Salt forms of 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide
08/18/2005CA2553604A1 New pyridin-2-one compounds useful as inhibitors of thrombin
08/18/2005CA2551566A1 Diurea derivatives
08/17/2005EP1564213A1 Imidazole derivative, process for producing the same, and use
08/17/2005EP1564212A1 Method and intermedia used to obtain derivatives of 1-(1h- benzimidazole-2-yl)-4-(2-aminopyrimidine)piperidine
08/17/2005EP1564210A1 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors
08/17/2005EP1562937A2 N-substituted piperidine derivatives as serotonin receptor agents
08/17/2005EP1562936A2 Therapeutic piperazine compounds
08/17/2005EP1562935A1 Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors
08/17/2005EP1562934A1 Amino-heterocycles as vr-1 antagonists for treating pain
08/17/2005EP1562933A2 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders
08/17/2005EP1562932A1 4-tetrazolyl-4-phenylpiperidine derivatives for treating pain
08/17/2005EP1562931A2 Anti-infective biaryl compounds
08/17/2005EP1562928A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
08/17/2005EP1562925A1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
08/17/2005EP1562911A1 Compositions useful as inhibitors of jak and other protein kinases
08/17/2005EP1562908A1 Quinoline derivatives
08/17/2005EP1562907A1 Pyridine derivatives as cb2 receptor modulators
08/17/2005EP1562903A2 Mucin synthesis inhibitors
08/17/2005EP1562898A1 Indole derivatives as somatostatin agonists or antagonists
08/17/2005EP1562891A1 4-aminomethyl-1-aryl-cyclohexylamine derivatives
08/17/2005EP1562599A1 Quaternary ammonium compounds as muscarinic receptor antagonists
08/17/2005EP1562596A1 Derivatives of pyridinalkyl-amonoalkyl-1h-indole inhibiting receptors 5-ht and recapture of serotonin which can be used as antidepressant and anxiolitic
08/17/2005EP1562595A1 Diaryl ethers as opioid receptor antagonists
08/17/2005EP1562589A2 Diaminotriazoles useful as inhibitors of protein kinases
08/17/2005EP1562574A1 2-oxo-ethanesulfonamide derivates
08/17/2005EP1562540A1 N-aryl-4,5-diaminopyrazols and dyes containing said compounds
08/17/2005EP1499594B1 Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles
08/17/2005EP1343761B1 Piperidine mch antagonists and their use in the treatment of obesity
08/17/2005EP1315496B1 The treatment of inflammatory disorders
08/17/2005EP1289951B1 Growth hormone secretagogues
08/17/2005EP1282418B1 Use of pyrazole derivatives for treating infertility
08/17/2005EP1266887B1 Indenoindoline derivatives, their process of preparation and pharmaceutical compositions containing them
08/17/2005EP1196397B1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
1 ... 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 ... 1080